Over 80% weighted distribution in Boots
prior to launch.
Under Ceuta guidance, Eroxon exceeded all brand-owner & retailer KPIs and generated a 36.8% market share in 3 months.
Contact Usprior to launch.
generated a spectacular sales response.
on Boots.com.
went to Eroxon, plus the brand became the No.1 best selling pack on Boots.com.
driven by national TV campaign.
achieved within 3 months.
interest triggered by launch success.
of the Best Big Budget OTC Campaign 2023 Award.
Eroxon's launch strategy included a 4-month period of offline retail exclusivity in Boots as it provides unparalleled consumer credentials in terms of accessibility and trust.
Secured Boots’ commitment to merchandising and training initiatives that provided shopper visibility and enabled staff to provide appropriate assurances at the point of purchase.
Developed a PR campaign that commenced on the first day of availability in Boots. Media coverage spanned online and offline channels and generated phenomenal sales results.
5-week TV campaign served to boost awareness further, triggering interest amongst first-time trialists that established Eroxon as the fastest-selling product on boots.com.
Internet search is known to be a key source of information within the erectile dysfunction category and Ceuta established a cost-effective presence for the brand in this important arena.